Montoir, D. | IICIMED

Montoir, D.

Publications

P212

 Eur. J. Med. Chem. 2020, 189, 112082.

New Azole Antifungals with a Fused Triazinone Scaffold.

Montoir, D. | Guillon, R. | Gazzola, S. | Ourliac-Garnier, I. | Efouako Soklou, K. | A Tonnerre, A. | Picot, C. | Planchat, A. | Pagniez, F. | Le Pape, P. | Logé, C.

doi: 10.1016/j.ejmech.2020.112082

P182

Tetrahedron Lett. 2018, 59, 3519-3523.

Novel approach towards 3,7-disubstituted 1,6-naphthyridin-4(1H)-ones exploiting cross-coupling and SNAr reactions of a dihalogenated compound.

Dembélé, O. | Montoir, D. | Yvorra, T. | Sérillon, D. | Tonnerre, A. | Duflos, M. | Robert, J.-M. | Bazin, M.-A.

doi: 10.1016/j.tetlet.2018.08.013

P168

X-Ray Struct. Anal. Online 2017, 33, 41-43.

Crystal structure of N-(7-{[2-(dimethylamino)ethyl]amino}-1-methyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-3,4,5-trimethoxybenzamide.

Guillon, J. | Montoir, D. | Marchivie, M. | Duflos, M. | Bazin, M.-A.

doi: 10.2116/xraystruct.33.41

P156

Eur. J. Med. Chem. 2016, 119, 17-33.

Novel 1,6-naphthyridin-2(1H)-ones as potential anticancer agents targeting Hsp90.

Montoir, D. | Barillé-Nion, S. | Tonnerre, A. | Juin, P. | Duflos, M. | Bazin, M.-A.

doi: 10.1016/j.ejmech.2016.04.050

P141

Tetrahedron 2015, 71, 3303-3313.

Efficient one-pot synthesis of 3,7-disubstituted 1,6-naphthyridin-2(1H)-ones through regioselective palladium-catalyzed cross-coupling and SNAr reactions.

Montoir, D. | Tonnerre, A. | Duflos, M. | Bazin, M.-A.

doi: 10.1016/j.tet.2015.03.110

P125

Eur. J. Org. Chem. 2014, 7, 1487-1495.

Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross-couplings.

Montoir, D. | Tonnerre, A. | Duflos, M. | Bazin, M.-A.

Autres publications scientifiques

Brevets

B17.

Novel fused pyrimidone and triazinone derivatives containing bridged nitrogen, their process of preparation and their therapeutic uses as antifungal and/or antiparasitic agents.

Logé, C. | Guillon, R. | Montoir, D. | Pagniez, F. | Le Pape, P.

PCT WO 2017/021178 A1, 9 février 2017.

Thèse

T30.

Synthèse de nouveaux analogues de la novobiocine, inhibiteurs potentiels de la Hsp90.

Montoir, D.

Nantes, date de soutenance : 08 octobre 2015.